Canada to donate AstraZeneca vaccine doses to African countries under COVAX scheme | Inquirer ºÚÁÏÉç

ºÚÁÏÉç

Canada to donate AstraZeneca vaccine doses to African countries under COVAX scheme

/ 04:37 PM September 02, 2021

astrazeneca vaccines

Vials labelled “Astra Zeneca COVID-19 Coronavirus Vaccine” and a syringe are seen in front of a displayed AstraZeneca logo, in this illustration photo taken March 14, 2021. REUTERS FILE PHOTO

Canada will donate more than 1.3 million doses of AstraZeneca’s COVID-19 vaccine to three African countries through the COVAX vaccine-sharing facility, GAVI said on Thursday.

Nigeria, Kenya and Niger will receive first shipments of the COVID-19 vaccines on Thursday, the Global Alliance for Vaccines and Immunization (GAVI) said.

Article continues after this advertisement

The COVAX facility, backed by the World Health Organization and GAVI, aims to secure 2 billion vaccine doses for lower income countries by the end of 2021.

FEATURED STORIES

RELATED STORIES

PH will contribute $1 million to COVAX facility – Duterte

Article continues after this advertisement

Over 2M COVAX-donated AstraZeneca COVID-19 jabs arrive in PH

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

For more news about the novel coronavirus click
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this

TAGS: Canada, Covax, COVID-19, Health

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2025 ºÚÁÏÉç | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.